Carvedilol Attenuates Inflammatory-Mediated Cardiotoxicity in Daunorubicin-Induced Rats.

about

Carvedilol Attenuates Inflammatory-Mediated Cardiotoxicity in Daunorubicin-Induced Rats.

Item

http://www.wikidata.org/entity/Q46930825

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Carvedilol Attenuates Inflammatory-Mediated Cardiotoxicity in Daunorubicin-Induced Rats.

@en

Carvedilol Attenuates Inflammatory-Mediated Cardiotoxicity in Daunorubicin-Induced Rats.

@nl

type

Item

label

Carvedilol Attenuates Inflammatory-Mediated Cardiotoxicity in Daunorubicin-Induced Rats.

@en

Carvedilol Attenuates Inflammatory-Mediated Cardiotoxicity in Daunorubicin-Induced Rats.

@nl

prefLabel

Carvedilol Attenuates Inflammatory-Mediated Cardiotoxicity in Daunorubicin-Induced Rats.

@en

Carvedilol Attenuates Inflammatory-Mediated Cardiotoxicity in Daunorubicin-Induced Rats.

@nl

P1476

Carvedilol Attenuates Inflammatory-Mediated Cardiotoxicity in Daunorubicin-Induced Rats

@en

P2093

Flori R. Sari

http://www.w3.org/2001/XMLSchema#string

Kenichi Watanabe

http://www.w3.org/2001/XMLSchema#string

Kenji Suzuki

http://www.w3.org/2001/XMLSchema#string

Makoto Kodama

http://www.w3.org/2001/XMLSchema#string

Meilei Harima

http://www.w3.org/2001/XMLSchema#string

Punniyakoti T. Veeravedu

http://www.w3.org/2001/XMLSchema#string

Rajarajan A. Thandavarayan

http://www.w3.org/2001/XMLSchema#string

Somasundaram Arumugam

http://www.w3.org/2001/XMLSchema#string

Vivian Soetikno

http://www.w3.org/2001/XMLSchema#string

Wawaimuli Arozal

http://www.w3.org/2001/XMLSchema#string

P2860

Risk factors for doxorubicin-induced congestive heart failure

Anthracycline cardiomyopathy monitored by morphologic changes

Protective effects of carvedilol against doxorubicin-induced cardiomyopathy in rats

Cardiac-targeted expression of soluble fas attenuates doxorubicin-induced cardiotoxicity in mice

Chronic anthracycline cardiotoxicity: haemodynamic and histopathological manifestations suggesting a restrictive endomyocardial disease.

Carvedilol-mediated antioxidant protection against doxorubicin-induced cardiac mitochondrial toxicity.

Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies.

Pharmacokinetic-pharmacodynamic relationships of the anthracycline anticancer drugs.

Inflammatory mediators and the failing heart: past, present, and the foreseeable future.

Predictors of inflammation in response to anthracycline-based chemotherapy for breast cancer.

P304

551-566

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/PH4030551

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P932

4053802

http://www.w3.org/2001/XMLSchema#string